Board Meetings - Vivimed Labs Ltd.

The latest board meeting for Vivimed Labs Ltd. took place on 14 Feb 2025, for the purpose of Quarterly Results

Ex-date Purpose Notes
14 Feb 2025 Quarterly Results -
10 Jan 2025 Quarterly Results & Others To consider other business matters.
14 Nov 2024 Audited Results & A.G.M. -
06 Sep 2024 Audited Results & A.G.M. -
05 Jul 2024 Others Inter alia, to consider and approv and To recommend the Appointment of Statutory Auditors to fill the Casual Vacancy Caused by Resignation.
14 Feb 2024 Quarterly Results -
14 Nov 2023 Quarterly Results -
14 Aug 2023 Quarterly Results -
30 May 2023 Quarterly Results -
13 Feb 2023 Quarterly Results -
13 Jan 2023 A.G.M. -
12 Aug 2022 Quarterly Results -
03 Jun 2022 Audited Results (Revised)
14 Feb 2022 Quarterly Results -
13 Nov 2021 Quarterly Results -
06 Sep 2021 Preferential issue of shares -
13 Aug 2021 Quarterly Results -
28 Jun 2021 Audited Results -
13 Feb 2021 Quarterly Results -
14 Nov 2020 Quarterly Results -
29 Aug 2020 Quarterly Results -
25 Jul 2020 Audited Results -
29 Jun 2020 Audited Results -
14 Feb 2020 Quarterly Results -
14 Nov 2019 Quarterly Results -
09 Aug 2019 Quarterly Results -
30 May 2019 Audited Results -
14 Feb 2019 Quarterly Results -
14 Nov 2018 Quarterly Results -
13 Aug 2018 Quarterly Results -
30 May 2018 Audited Results & Dividend -
22 Mar 2018 Others 1. Issuance of warrants on preferential basis to the Promoters/ Promoter Group entities and other Non- promoters, of the Company.
14 Feb 2018 Quarterly Results -
14 Nov 2017 Quarterly Results -
12 Aug 2017 Quarterly Results -
27 May 2017 Audited Results & Dividend -
14 Feb 2017 Quarterly Results -
12 Jan 2017 Quarterly Results -
12 Nov 2016 Quarterly Results -
30 May 2016 Audited Results & Dividend No Dividend is recommended for the Financial Year 2015-16.
23 Apr 2016 Others Appointment of Chief Executive Officer: Mr. Pavan Kumar M. has been appointed as the Chief Executive Officer (CEO) of the company.
13 Feb 2016 Quarterly Results -
11 Jan 2016 Stock Split 1. The sub division of equity shares of Rs.10/- each into shares with lower face value. 2. Resignation of Mr. Srinivas Chidambaram from the Board of Directors of the Company.
10 Nov 2015 Quarterly Results -
12 Sep 2015 Others In order to optimise the capital structure of the Company and, prepare for the next leg of growth across its business units, and post an ongoing review of the strategic options available.
14 Aug 2015 Quarterly Results Appointment of Mr. Amarjit Singh Bhatia, as the Chief Financial Officer of the Company effective August 14, 2015.
30 May 2015 Audited Results -
13 Feb 2015 Quarterly Results -
12 Nov 2014 Quarterly Results -
13 Aug 2014 Quarterly Results -
29 May 2014 Audited Results & Dividend -
13 Feb 2014 Quarterly Results -
13 Nov 2013 Quarterly Results -
13 Aug 2013 Quarterly Results -
24 May 2013 Audited Results & Dividend -
13 Feb 2013 Quarterly Results -
12 Nov 2012 Quarterly Results -
13 Aug 2012 Quarterly Results -
30 May 2012 Audited Results & Final Dividend -
13 Feb 2012 Quarterly Results -
14 Nov 2011 Quarterly Results -
13 Aug 2011 Quarterly Results -
27 May 2011 Audited Results -
29 Jan 2011 Quarterly Results -
23 Oct 2010 Quarterly Results -
09 Oct 2010 To consider further capital issue -
16 Aug 2010 Quarterly Results (Board meeting adjourned from 14/08/2010)
29 May 2010 Audited Results -
24 Apr 2010 Issue of Convertible Warrants The Board has resolved to issue of 14,90,000 Warrants Convertible into Equity Shares of Rs. 10/- each at a premium of Rs. 140/- each to Promoters & Others for which the Company.
05 Feb 2010 To re-consider the Allotment of Warrats To issue of 15,00,000 Warrants at a issue price of Rs. 150 per Warrant determined in accordance with relevant SEBI Regulations, Conv. into Equity Shares of Rs. 10 fully paid up for each Warrant.
29 Jan 2010 Quarterly Results -
27 Oct 2009 Quarterly Results -
16 Oct 2009 Issue of Preferential Shares / Warrants To consider the Preferential Issue of upto 15,00,000 Warrants, convertible into Equity Shares at a issue price of Rs. 120 per Warrant determined in accordance with relevant SEBI Regulations.
31 Jul 2009 Quarterly Results -
30 Jun 2009 Audited Results & Dividend To recommend a dividend of Rs. 1.50 per equity shares (15%) amounting to Rs. 141 Lakhs plus tax on dividend of Rs. 23.96 Lakhs.
21 Jan 2009 Quarterly Results -
29 Oct 2008 Quarterly Results -
31 Jul 2008 Quarterly Results -
28 Jun 2008 Audited Results & Others To consider the Proposal of cancellation of Preferential issue of shares / warrants to promoters, Promoter groups and others.
13 Mar 2008 Investment in Vivimed Holdings Ltd. 1. To consider the proposal of investment in Vivimed Holdings Ltd, a 100% Subsidiary of the Company. 2. To consider the proposal of providing Corporate Guarantee to the lender to Vivimed Holdings.
23 Jan 2008 Quarterly Results -
26 Dec 2007 Audited Financial Results inter alia, to consider & take on record and approve the Audited Financial Results (post merger with VVS Pharmaceuticals Pvt Ltd) for the year ended March 31, 2007.
03 Dec 2007 Audited Results & Others 1. The Proposal of issue of Shares / warrants by way of preferential basis. 2. The Proposal for the Enhancement of Borrowing limits to the Board & 3. The allotment of Shares pursuant to the Merger.
31 Oct 2007 Quarterly Results -
27 Jul 2007 Quarterly Results -
30 Apr 2007 Quarterly Results -
30 Jan 2007 Quarterly Results -
02 Dec 2006 Preferential Issue of shares -
30 Oct 2006 Quarterly Results -
28 Aug 2006 Accounts & Dividend -
28 Jul 2006 Quarterly Results -
15 May 2006 To conside issue of securities Issue of securities in the form of Global Depository Receipts / Foreign Currency Convertible Bonds or otherwise.
29 Apr 2006 Quarterly Results & Merger The proposed merger of M/s VVS Pharmaceuticals & Chemicals Pvt Ltd, (Transferor Company) with the Company (Transferee Company).
25 Jan 2006 Quarterly Results -
24 Oct 2005 Quarterly Results -